5291 - 5300 of 8571 Results
Title
Year
- Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy Bodies2021OPENTitle: Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy BodiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 80Issue #: 4Start Page: 1603End Page: 1612Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-200323Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10109539Citation Count: 4
- Identification of risk factors for impulse-control disorder symptoms in patients with Parkinson’s disease2021OPENTitle: Identification of risk factors for impulse-control disorder symptoms in patients with Parkinson’s diseaseJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012099End Page: 012099Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012099Best OA location URL: https://iopscience.iop.org/article/10.1088/1742-6596/1722/1/012099/pdfCitation Count: 1
- Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations2021RESTRICTEDTitle: Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter AlterationsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 82Issue #: s1Start Page: S5End Page: S18Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-201195Citation Count: 9
- Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive Impairment2021RESTRICTEDTitle: Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive ImpairmentJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 82Issue #: 2Start Page: 541End Page: 560Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-201457Citation Count: 23
- Improving Patient Outreach by Defining Telehealth Suitability in a Tertiary Huntington’s Disease Clinic2021RESTRICTEDTitle: Improving Patient Outreach by Defining Telehealth Suitability in a Tertiary Huntington’s Disease ClinicJournal Name: Journal of Huntington's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 479End Page: 484Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jhd-210498Citation Count: 4
-
OPENTitle: Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 177End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202285?id=journal-of-parkinsons-disease%2Fjpd202285Citation Count: 49
- Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study2021OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 47
- The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers2021OPENTitle: The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their CarersJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1309End Page: 1323Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212611Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212611?id=journal-of-parkinsons-disease%2Fjpd212611Citation Count: 15
- Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease2022OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 6
- Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial2022OPENTitle: Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trialJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 3Start Page: 857End Page: 860Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brs.2022.05.012Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X22000912/pdfCitation Count: 19